Aprea Therapeutics (APRE)
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeut...
- Open
- 0.7800
- High
- 0.9000
- Low
- 0.7795
- Prev. Close
- 0.8000
- Volume
- 460.49K
- Turnover
- 390.73K
- Avg Price
- 0.8485
- Bid/Ask Ratio
- 42.86%
- Amplitude
- 15.06%
- 52wk High
- 1.6900
- Volume Ratio
- 14.75
- Turnover Ratio
- 5.82%
Aprea Therapeutics Analyst Rating
View moreForecast & Rating
Aug 13, 2026Price forecast
$3.55324.79%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 10 hours ago
Virgin Galactic's Space Tourism Resumes and Twilio Surges: Key Moves Across Uncategorized US Stocks
- StockTitan · Aug 28 at 04:15 AM
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs | APRE Stock News
- benzinga_article · Aug 27 at 05:06 PM
12 Health Care Stocks Moving In Thursday's Intraday Session
- Global Report · Aug 25 at 10:12 AM
The Market's Hidden Corners: From Copper Mines to AI Assembly, the Overlooked US Narratives
